microRNA 3660 (MIR3660)

microRNA 3660 (MIR3660) is a human gene encoding a microRNA, classified as a small, non-coding RNA molecule. MicroRNAs typically function by binding to complementary sequences within messenger RNA (mRNA) molecules, leading to the suppression of gene expression either through inhibition of translation or mRNA degradation[1][4]. miRNAs are central regulators of many physiological and disease processes, including cell differentiation, proliferation, apoptosis, and cancer development[1][2][4]. The MIR3660 gene produces the mature miR-3660 molecule via the standard microRNA biogenesis pathway involving DROSHA and DICER processing enzymes[1]. Unlike protein targets (e.g., receptors, enzymes), microRNAs do not act as direct drug targets themselves, but they are often involved in disease mechanisms and are under investigation as disease biomarkers or indirect therapeutic targets in oncology and other fields[2][4]. There is currently minimal evidence for direct pharmacological modulation of MIR3660 or drugs interacting with MIR3660 specifically. Key points: - MIR3660 belongs to the microRNA gene family, not a classical drug target class like receptor, enzyme, or transporter[1]. - It is being explored as a biomarker, especially in cancer research, reflecting broader roles for miRNAs in disease[2]. - There is no current drug known to target MIR3660 directly. - MicroRNAs, including MIR3660, regulate gene expression post-transcriptionally, impacting diverse cellular pathways[1][4].

Other names

hsa-mir-3660mir-3660